Nipa has arrived—are you afraid?

In 2023, the World Health Organization once again added Nipah virus to its list of “priority pathogens.” This virus, whose natural reservoir is fruit bats and which carries a high fatality rate with no specific treatment, has repeatedly strained global public health systems whenever an outbreak occurs.

Its symptoms are insidious, its modes of transmission are diverse, and its incubation period is variable—Nipah virus is like a latent “biological threat.” In the face of it, Rapid, accurate, and early diagnosis It is the first—and most critical—line of defense in breaking the chain of transmission and safeguarding public health.

Ningpu Medical: Providing comprehensive, highly reliable testing solutions for the prevention and control of Nipah virus.

Jiangsu Ningpu Medical care , as a trusted partner in the fields of in vitro diagnostics and life sciences, leveraging a robust R&D platform, it has now launched products that cover Antibody testing, nucleic acid testing, antigen preparation, and quality control validation A comprehensive Nipah virus product portfolio, supporting enhanced research capabilities and public health preparedness.

Core products, targeted strikes

1. Nipah Virus Nucleic Acid Detection Kit (Fluorescent PCR Method)

The gold standard and an early “scout”: a highly sensitive fluorescent probe–based assay for direct detection of viral nucleic acids.
Rapid and accurate: It enables swift screening and definitive diagnosis even in the early stages of infection—before symptoms appear—buying valuable time for prevention and control.
High specificity: effectively avoids cross-reactivity with other paramyxoviruses, ensuring accurate and reliable results.

2. Nipah Virus N Protein Antibody Detection Kit (ELISA)

Tracing infection and assessing immunity: for the detection of IgG/IgM antibodies specific to the N protein of the Nipah virus in serum/plasma.
A powerful tool for epidemiological investigations: suitable for retrospective diagnosis, infection source tracing, and monitoring population immunity levels, providing serological evidence to inform prevention and control strategies.
Stable and efficient: easy to operate, high throughput, and suitable for large-scale screening.

3. Nipah virus recombinant N protein (eukaryotic expression) & Nipah virus pseudovirus

Recombinant N protein (eukaryotic expression): Retains the native protein structure and antigenicity, serving as a critical raw material for the development of antibody detection assays, the preparation of reference standards, and immunological research.
Pseudovirus (fused with G/F genes): Carries key glycoprotein genes and features safety and non‑replicative properties, making it an ideal tool for viral neutralizing antibody assays, drug screening, studies of viral entry mechanisms, and laboratory quality control. It serves as a perfect substitute for live virus, ensuring experimental safety.

Establish a comprehensive technological closed loop, spanning from screening to research.

Ningpu Medical care of the Nipah virus product portfolio, forming a continuum from “Early nucleic acid diagnosis” → “Later antibody tracing” → “Basic research and quality-control validation” A complete closed-loop solution. Whether it’s cutting-edge research, vaccine evaluation, or the development and quality control of clinical diagnostic reagents, we can provide reliable product support.